Neuralink Advances New Brain-Computer Interface, Exploring New Possibilities for Thought-Based Communication and Vision Restoration | WPN World People News

U.S. entrepreneur Elon Musk’s brain-computer interface company Neuralink announced two implantable technologies on October 30: “Telepathy” and “Blindsight,” highlighting the potential of neurotechnology in medical assistance and human-computer interaction.

Telepathy is the company’s first product. It primarily works by receiving neural activity signals from the brain to help people with limited mobility or paralysis control computers. Users do not need to rely on traditional keyboards; they can type text, operate devices, and even communicate in daily life using brain signals alone. Musk expects that information transmission through this technology could eventually surpass the speed of ordinary speech and typing.

The other technology, Blindsight, focuses on restoring visual function. It uses imaging equipment to capture images of the external environment and then transmits the relevant information directly to the brain regions responsible for visual processing. By bypassing damaged eyeballs and optic nerves, the technology aims to help people who are completely blind or have congenital vision loss perceive images again.

In September 2024, the U.S. Food and Drug Administration (FDA) granted Blindsight Breakthrough Device Designation, potentially accelerating subsequent review procedures. However, this designation is not formal marketing approval and does not mean that the technology’s effectiveness has been proven. Blindsight remains in the research stage, and no publicly disclosed results have yet demonstrated restored vision in human subjects.

In addition, Neuralink released preliminary findings from its VOICE clinical study, demonstrating how participants used brain signals to make phone calls, enter text on mobile phones, and even activate AI agents to perform computer tasks. These developments point to a new avenue of communication for people who have lost the ability to speak.

Overall, brain-computer interfaces are gradually expanding beyond reading neural signals to transmitting sensory information. However, implant safety, practical effectiveness, and regulatory approval remain major challenges. Whether experimental results can be transformed into reliable medical applications will depend on further clinical data and scientific validation.